Synthesis and In Vitro Antibacterial Activity of Novel 3-Azabicyclo[3.3.0]octanyl Oxazolidinones

Deepak Bhattarai, Sun H. Lee, Seon H. Seo, Ghilsoo Nam, Soon B. Kang, Ae N. Pae, Eunice E. Kim, Taegwon Oh, Sang Nae Cho, Gyochang Keum

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

We synthesized a series of oxazolidinone-type antibacterials in which morpholine C-ring of linezolid has been modified by substituted 3-azabicyclo[3.3.0]octanyl rings. Acetamide or 1,2,3-triazole heterocycle was used as C-5 side chain of oxazolidinone. The resulting series of compounds was then screened in vitro against panel of susceptible and resistant Gram-positive, Gram-negative bacteria, and Mycobacterium tuberculosis (Mtb). Several analogs in this series exhibited potent in vitro antibacterial activity comparable or superior to linezolid against the tested bacteria. Compounds 10a, 10b, 11a, and 15a displayed highly potent activity against M. tuberculosis. Selected compound 10b showed good human microsomal stability and CYP-profile, and showed low activity against hERG channel. We synthesized a series of oxazolidinone-type antibacterials in which morpholine C-ring of linezolid has been modified by substituted 3-azabicyclo[3.3.0]octanyl rings, and acetamide or 1,2,3-triazole heterocycle was used as C-5 side chain of oxazolidinone. Several analogs in this series exhibited potent in vitro antibacterial activity comparable or superior to linezolid against panel of susceptible and resistant Gram-positive, Gram-negative bacteria and Mycobacterium tuberculosis (Mtb). Compounds 10a, 10b, 11a, and 15a displayed highly potent activity against M. tuberculosis.

Original languageEnglish
Pages (from-to)388-397
Number of pages10
JournalChemical Biology and Drug Design
Volume80
Issue number3
DOIs
Publication statusPublished - 2012 Sep 1

Fingerprint

Linezolid
Oxazolidinones
Mycobacterium tuberculosis
Bacteria
Triazoles
Gram-Negative Bacteria
In Vitro Techniques

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Organic Chemistry

Cite this

Bhattarai, Deepak ; Lee, Sun H. ; Seo, Seon H. ; Nam, Ghilsoo ; Kang, Soon B. ; Pae, Ae N. ; Kim, Eunice E. ; Oh, Taegwon ; Cho, Sang Nae ; Keum, Gyochang. / Synthesis and In Vitro Antibacterial Activity of Novel 3-Azabicyclo[3.3.0]octanyl Oxazolidinones. In: Chemical Biology and Drug Design. 2012 ; Vol. 80, No. 3. pp. 388-397.
@article{b0853e78f4c94c56bd5e4960cb8935f0,
title = "Synthesis and In Vitro Antibacterial Activity of Novel 3-Azabicyclo[3.3.0]octanyl Oxazolidinones",
abstract = "We synthesized a series of oxazolidinone-type antibacterials in which morpholine C-ring of linezolid has been modified by substituted 3-azabicyclo[3.3.0]octanyl rings. Acetamide or 1,2,3-triazole heterocycle was used as C-5 side chain of oxazolidinone. The resulting series of compounds was then screened in vitro against panel of susceptible and resistant Gram-positive, Gram-negative bacteria, and Mycobacterium tuberculosis (Mtb). Several analogs in this series exhibited potent in vitro antibacterial activity comparable or superior to linezolid against the tested bacteria. Compounds 10a, 10b, 11a, and 15a displayed highly potent activity against M. tuberculosis. Selected compound 10b showed good human microsomal stability and CYP-profile, and showed low activity against hERG channel. We synthesized a series of oxazolidinone-type antibacterials in which morpholine C-ring of linezolid has been modified by substituted 3-azabicyclo[3.3.0]octanyl rings, and acetamide or 1,2,3-triazole heterocycle was used as C-5 side chain of oxazolidinone. Several analogs in this series exhibited potent in vitro antibacterial activity comparable or superior to linezolid against panel of susceptible and resistant Gram-positive, Gram-negative bacteria and Mycobacterium tuberculosis (Mtb). Compounds 10a, 10b, 11a, and 15a displayed highly potent activity against M. tuberculosis.",
author = "Deepak Bhattarai and Lee, {Sun H.} and Seo, {Seon H.} and Ghilsoo Nam and Kang, {Soon B.} and Pae, {Ae N.} and Kim, {Eunice E.} and Taegwon Oh and Cho, {Sang Nae} and Gyochang Keum",
year = "2012",
month = "9",
day = "1",
doi = "10.1111/j.1747-0285.2012.01404.x",
language = "English",
volume = "80",
pages = "388--397",
journal = "Chemical Biology and Drug Design",
issn = "1747-0277",
publisher = "Blackwell",
number = "3",

}

Bhattarai, D, Lee, SH, Seo, SH, Nam, G, Kang, SB, Pae, AN, Kim, EE, Oh, T, Cho, SN & Keum, G 2012, 'Synthesis and In Vitro Antibacterial Activity of Novel 3-Azabicyclo[3.3.0]octanyl Oxazolidinones', Chemical Biology and Drug Design, vol. 80, no. 3, pp. 388-397. https://doi.org/10.1111/j.1747-0285.2012.01404.x

Synthesis and In Vitro Antibacterial Activity of Novel 3-Azabicyclo[3.3.0]octanyl Oxazolidinones. / Bhattarai, Deepak; Lee, Sun H.; Seo, Seon H.; Nam, Ghilsoo; Kang, Soon B.; Pae, Ae N.; Kim, Eunice E.; Oh, Taegwon; Cho, Sang Nae; Keum, Gyochang.

In: Chemical Biology and Drug Design, Vol. 80, No. 3, 01.09.2012, p. 388-397.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Synthesis and In Vitro Antibacterial Activity of Novel 3-Azabicyclo[3.3.0]octanyl Oxazolidinones

AU - Bhattarai, Deepak

AU - Lee, Sun H.

AU - Seo, Seon H.

AU - Nam, Ghilsoo

AU - Kang, Soon B.

AU - Pae, Ae N.

AU - Kim, Eunice E.

AU - Oh, Taegwon

AU - Cho, Sang Nae

AU - Keum, Gyochang

PY - 2012/9/1

Y1 - 2012/9/1

N2 - We synthesized a series of oxazolidinone-type antibacterials in which morpholine C-ring of linezolid has been modified by substituted 3-azabicyclo[3.3.0]octanyl rings. Acetamide or 1,2,3-triazole heterocycle was used as C-5 side chain of oxazolidinone. The resulting series of compounds was then screened in vitro against panel of susceptible and resistant Gram-positive, Gram-negative bacteria, and Mycobacterium tuberculosis (Mtb). Several analogs in this series exhibited potent in vitro antibacterial activity comparable or superior to linezolid against the tested bacteria. Compounds 10a, 10b, 11a, and 15a displayed highly potent activity against M. tuberculosis. Selected compound 10b showed good human microsomal stability and CYP-profile, and showed low activity against hERG channel. We synthesized a series of oxazolidinone-type antibacterials in which morpholine C-ring of linezolid has been modified by substituted 3-azabicyclo[3.3.0]octanyl rings, and acetamide or 1,2,3-triazole heterocycle was used as C-5 side chain of oxazolidinone. Several analogs in this series exhibited potent in vitro antibacterial activity comparable or superior to linezolid against panel of susceptible and resistant Gram-positive, Gram-negative bacteria and Mycobacterium tuberculosis (Mtb). Compounds 10a, 10b, 11a, and 15a displayed highly potent activity against M. tuberculosis.

AB - We synthesized a series of oxazolidinone-type antibacterials in which morpholine C-ring of linezolid has been modified by substituted 3-azabicyclo[3.3.0]octanyl rings. Acetamide or 1,2,3-triazole heterocycle was used as C-5 side chain of oxazolidinone. The resulting series of compounds was then screened in vitro against panel of susceptible and resistant Gram-positive, Gram-negative bacteria, and Mycobacterium tuberculosis (Mtb). Several analogs in this series exhibited potent in vitro antibacterial activity comparable or superior to linezolid against the tested bacteria. Compounds 10a, 10b, 11a, and 15a displayed highly potent activity against M. tuberculosis. Selected compound 10b showed good human microsomal stability and CYP-profile, and showed low activity against hERG channel. We synthesized a series of oxazolidinone-type antibacterials in which morpholine C-ring of linezolid has been modified by substituted 3-azabicyclo[3.3.0]octanyl rings, and acetamide or 1,2,3-triazole heterocycle was used as C-5 side chain of oxazolidinone. Several analogs in this series exhibited potent in vitro antibacterial activity comparable or superior to linezolid against panel of susceptible and resistant Gram-positive, Gram-negative bacteria and Mycobacterium tuberculosis (Mtb). Compounds 10a, 10b, 11a, and 15a displayed highly potent activity against M. tuberculosis.

UR - http://www.scopus.com/inward/record.url?scp=84864135918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864135918&partnerID=8YFLogxK

U2 - 10.1111/j.1747-0285.2012.01404.x

DO - 10.1111/j.1747-0285.2012.01404.x

M3 - Article

C2 - 22553981

AN - SCOPUS:84864135918

VL - 80

SP - 388

EP - 397

JO - Chemical Biology and Drug Design

JF - Chemical Biology and Drug Design

SN - 1747-0277

IS - 3

ER -